Hypertension pharmacology slides
Summary
Gain valuable insights into hypertension and its management in this in-depth on-demand teaching session led by Tanya Jayakar. Learn about the intricacies of various hypertensives such as CCB, ACEi, ARB, and Thiazides, along with a detailed explanation of their mechanism of actions. The session also covers the treatment guidelines provided by NICE, and the pharmacokinetics of common drugs used. With case studies illustrating the ideal use of different drugs in different patients, this session will entice and captify medical professionals keen on expanding their knowledge regarding drug choice for hypertension based on patient demographics and co-morbidities.
Learning objectives
- Understand the definition and importance of hypertension in relation to cardiovascular risk.
- Identify the different treatment options for hypertension including the use of CCB, ACEi, ARB, and Thiazides.
- Comprehend the treatment guidelines as outlined by NICE for the management of hypertension.
- Understand the pharmacokinetics of different antihypertensive drugs and their pro-drug forms.
- Apply the knowledge of antihypertensive medications to various patient scenarios and determine the most appropriate course of treatment.
Similar communities
Similar events and on demand videos
Computer generated transcript
Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.
)ZQFSUFOTJPO Tanya Jayakar tanya.jayakar21@imperial.ac.uk8IBU▯XFsSF▯HPJOH▯UP▯DPWFS▯ • What is hypertension? • Why do I care? • QRISK & cardiovascular risk • What can I d? • CCB • ACEi • ARB • Thiazides • Treatment guidelines (NICE) • Pharmacokinetics • Pro-drugsHypertension???8IP▯IBT▯IZQFSUFOTJPO A. Lucy measured her blood pressure at home once as 149/85 B. Kamal’s blood pressure was 162/92 at the GP , but 134/78 average with ABPM C. Niamh’s NP was 138/121 when measured by the nurse in clinic D. Kal has been measuring his blood pressure twice daily at home and it was around 118/848IP▯IBT▯IZQFSUFOTJPO A. Lucy measured her blood pressure at home once as 149/85 B. Kamal’s blood pressure was 162/92 at the GP , but 134/78 average with ABPM C. Niamh’s BP was 138/121 when measured by the nurse in clinic D. Kal has been measuring his blood pressure twice daily at home and it was around 118/84Hypertension: so what?8IFSF▯EP▯$$#T▯BDU▯GPS▯UIFJS▯BOUJ▯IZQFSUFOTJWF▯FGGFDU A. Kidneys B. Heart C. Vascular smooth muscle D. Brain8IFSF▯EP▯$$#T▯BDU▯GPS▯UIFJS▯BOUJ▯IZQFSUFOTJWF▯FGGFDU A. Kidneys B. Heart C. Vascular smooth muscle D. Brain$$#T Mechanism of action Amlodipine, felodipine Block L-type calcium channels, predominantly on vascular smooth muscle Dihydropyridine type calcium channel blockers Results in decrease in calcium influx and downstream demonstrate a higher degree of vascular selectivity inhibition of myosin light chain kinase and prevention of cross-bridge formation Resultant vasodilation reduces peripheral resistance Side effects • Ankle oedema • Constipation • Palpitations • Flushing/headache8IJDI▯PG▯UIF▯GPMMPXJOH▯TUBUFNFOUT▯JT▯DPSSFDU A. ARBs cause a dry cough B. Both ACEis and ARBs inhibit renin production C. ACEis prevent vasoconstriction while ARBs reduce aldosterone production D. Both ACEis and ARBs can cause hyperkalaemia8IJDI▯PG▯UIF▯GPMMPXJOH▯TUBUFNFOUT▯JT▯DPSSFDU A. ARBs cause a dry cough B. Both ACEis and ARBs inhibit renin production C. ACEis prevent vasoconstriction while ARBs reduce aldosterone production D. Both ACEis and ARBs can cause hyperkalaemia"$&J▯BOE▯"3# Mechanism of action ACE: Ramipril, Lisinopril, Perindopril ACEi-> prevents conversion of Ang I to Ang II ARB: Losartan, Irbesartan, Candesartan ARB-> non-competitive antagonists at AT1 receptor on kidneys and vasculature Most ACE inhibitors (not lisinopril) are prodrugs so require hepatic activation to have an effect eGFR and serum K+ must be regularly monitored when prescribing ACE inhibitors. Losartan and candesartan are also prodrugs. ARBs are not as effective antihypertensives as ACEi Side effects • Hypotension • Hyperkalaemia (care with K+ supplements or K+ sparing diuretics) • Foetal injury (avoid in pregnant women) • Renal failure (in renal artery stenosis patients) • Urticaria (hives)/angioedema (swelling under skin) • ACEi: cough due to bradykininACE is involved in breakdown of bradykinin. ACEi cause accumulation of bradykinin and prostaglandins which stimulate cough receptors8IJDI▯PG▯UIF▯GPMMPXJOH▯TUBUFNFOUT▯JT▯DPSSFDU A. Thiazides have a long lasting diuretic effect B. Thiazides act in the proximal convoluted tubule C. Thiazides cause more dilute urine production D. Thiazides cause increased Cl- excretion in the urine8IJDI▯PG▯UIF▯GPMMPXJOH▯TUBUFNFOUT▯JT▯DPSSFDU A. Thiazides have a long lasting diuretic effect B. Thiazides act in the proximal convoluted tubule C. Thiazides cause more dilute urine production D. Thiazides cause increased Cl- excretion in the urine5IJB[JEFT Mechanism of action Bendro-flumethiazide (thiazide) Block Na+ Cl- cotransporter in early DCT Indapamide (thiazide-like) Ø Na+ and Cl- reabsorption inhibited Ø Osmolarity of tubular fluid increases, decreasing Lose diuretic effects in 1-2 weeks of treatment the osmotic gradient for water reabsorption in Continuing antihypertensive action appears to be due collecting duct to vasodilating properties (more pronounced for thiazide-like diuretics) Side effects Hypokalaemia Hyponatraemia Metabolic alkalosis (increased H+ excretion) Hypercalcaemia Hyperglycaemia (hyperpolarised pancreatic beta cells) Hyperuricaemia8IJDI▯PG▯UIF▯GPMMPXJOH▯DPSSFDUMZ▯NBUDIFT▯UIF▯ ESVH▯UP▯UIF▯TUBHF▯▯▯IZQFSUFOTJPO▯QBUJFOU A. Muhammad is 45, of Middle Eastern origin and has T2DM; ACEi B. Calorine is 35, of British Asian origin and has no comorbidities; CCB C. James is 65, an Irish Traveller and has no comorbidities; ARB D. Harmony is 73, of Afro-Carribean origin and has T2DM; Thiazide8IJDI▯PG▯UIF▯GPMMPXJOH▯DPSSFDUMZ▯NBUDIFT▯UIF▯ ESVH▯UP▯UIF▯TUBHF▯▯▯IZQFSUFOTJPO▯QBUJFOU A. Muhammad is 45, of Middle Eastern origin and has T2DM; ACEi B. Calorine is 35, of British Asian origin and has no comorbidities; CCB C. James is 65, an Irish Traveller and has no comorbidities; ARB D. Harmony is 73, of Afro-Carribean origin and has T2DM; Thiazide)PX▯UP▯BQQSPBDI▯B▯)5/▯QSFTDSJCJOH▯2 1. Do they have T2DM? -> YES: ARB (Afro-Caribbean) or ACEi 2. Are they of Afro-Caribbean origin? -> YES: CCB 3. Are they over 55? -> YES: CCB 4. NO: ACEi 5. If they’re already medicated: add whatever they don’t have NO THIAZIDES FOR DIABETICS1IBSNBDPLJOFUJDT8IJDI▯PG▯UIF▯GPMMPXJOH▯DBO▯CF▯EFEVDFE▯GSPN▯ UIF▯UBCMF A. A day after taking the tablet, there is no felodipine left in the body B. It could be appropriate to take a dose of amlodipine every 2 days C. After 12 hours, no amlodipine is detectable in the plasma D. The kidneys remove 11mL/min/kg of amlodipine from the plasma8IJDI▯PG▯UIF▯GPMMPXJOH▯DBO▯CF▯EFEVDFE▯GSPN▯ UIF▯UBCMF A. A day after taking the tablet, there is no felodipine left in the body B. It could be appropriate to take a dose of amlodipine every 2 days C. After 12 hours, no amlodipine is detectable in the plasma D. The kidneys remove 11mL/min/kg of amlodipine from the plasma1SP▯ESVHT Ramipril (&most ACEis) Lisinopril5)"/,▯:06▯ Please fill in the Feedback form! Name: T anya Jayakar Email: tvj21@ic.ac.uk tion=imperial-pharmacology-ning/feedback/anonymous?organisa society&keyword=ecdb6d067f045960da2d5b4bHypertension •Angiotensin converting enzyme inhibitors (Ramipril, Lisinopril, Perindopril) •Calcium channel blockers (Amlodipine, Felodipine) •Thiazide or thiazide-like diuretics (Bendro-flumethiazide (thiazide), Indapamide (thiazide-like)) •Angiotensin receptor blockers (Losartan, Irbesartan, Candesartan)